License, Collaboration and Other Significant Agreements - Janssen Pharmaceutica NV Research and License Agreement (Details) - Development And Commercialize Research And License Agreement - USD ($) $ / shares in Units, $ in Millions |
Feb. 09, 2017 |
Mar. 31, 2017 |
---|---|---|
Janssen Pharmaceutica NV | ||
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||
Collaborative arrangement, term | 3 years | |
Upfront payment made in cash | $ 1.0 | |
Potential milestone revenue from developmental milestones (up to) | 16.5 | |
Potential milestone revenue from commercial milestones (up to) | $ 215.0 | |
Johnson & Johnson Innovation | ||
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||
Warrant to purchase common stock (in shares) | 509,611 | |
Exercise price (in dollars per share) | $ 9.81 | |
Fair value of warrant at issuance | $ 3.4 |